
CXCR4 antagonism in combination with IDO1 inhibition weakens immune su | OTT Dove Medical Press
CXCR4 antagonism in combination with IDO1 inhibition weakens immune suppression and inhibits tumor growth in mouse breast cancer bone metastases.
“ovarian cancer” – Google News
